Home LiteratureArticle Details
PMID: 25753425 Published · ppublish English Journal Article

M-CSF from Cancer Cells Induces Fatty Acid Synthase and PPARβ/δ Activation in Tumor Myeloid Cells, Leading to Tumor Progression.

Cell reports ·Vol. 10 ·No. 9 ·2015-03-10 ·Pages 1614-1625

Park J, Lee SE, Hur J, Hong EB, Choi JI, Yang JM, Kim JY, Kim YC, Cho HJ, Peters JM, Ryoo SB, Kim YT, Kim HS

Abstract

We investigate crosstalk between cancer cells and stromal myeloid cells. We find that Lewis lung carcinoma cells significantly induce PPARβ/δ activity in myeloid cells in vitro and in vivo. Myeloid cell-specific knockout of PPARβ/δ results in impaired growth of implanted tumors, and this is restored by adoptive transfer of wild-type myeloid cells. We find that IL-10 is a downstream effector of PPARβ/δ and facilitates tumor cell invasion and angiogenesis. This observation is supported by the finding that the CD11blowIL-10+ pro-tumoral myeloid cell is scarcely detected in tumors from myeloid-cell-specific PPARβ/δ knockout mice, where vessel densities are also decreased. Fatty acid synthase (FASN) is shown to be an upstream regulator of PPARβ/δ in myeloid cells and is induced by M-CSF secreted from tumor cells. Our study gives insight into how cancer cells influence myeloid stromal cells to get a pro-tumoral phenotype.

Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Park Jonghanne
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea; Cardiovascular Center and Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea.
Lee Sang Eun
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea; Cardiovascular Center and Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea.
Hur Jin
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea.
Hong Eun Byeol
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea.
Choi Jae-Il
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea.
Yang Ji-Min
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea.
Kim Ju-Young
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea.
Kim Young-Chan
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea.
Cho Hyun-Jai
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea; Cardiovascular Center and Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea.
Peters Jeffrey M
Department of Veterinary and Biomedical Sciences and Center for Molecular Toxicology and Carcinogenesis, Pennsylvania State University, University Park, PA 16802, USA.
Ryoo Seung-Bum
Department of Surgery, Seoul National University College of Medicine, Seoul 110-744, Korea.
Kim Young Tae
Department of Thoracic and Cardiovascular Surgery, Biomedical Research Institute, Seoul National University Hospital, Seoul 110-744, Korea.
Kim Hyo-Soo
National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea; Cardiovascular Center and Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea; Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science Technology, Seoul National University, Seoul 110-799, Korea. Electronic address: hyosoo@snu.ac.kr.
Article Info
Journal
Cell reports
Abbr.
Cell Rep
ISSN
2211-1247
Published
2015-03-10
Epub
2015-00-05
Pages
1614-1625
Language
English
Region
United States
NLM ID
101573691
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com